CIK 0000725363
- Non-accelerated filer
- Smaller reporting company
CEL SCI CORP
Sign in to watch- Ticker
- CVM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- CO
- Entity type
- Operating
- EIN
- 840916344
- Phone
- +1 703-506-9460
- Business address
- 8229 BOONE BLVD ., SUITE 802, VIENNA, VA, 22182
- 4 Grant or award CEO acquired 12,940 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 6,001 shares (grant or award)
- 4 Grant or award Chief Financial & Operations acquired 10,727 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 2,264 shares (grant or award)
- 4 Grant or award Sr. VP of Operations acquired 4,047 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 4,882 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 2,068 shares (grant or award)
- 4 Grant or award Senior Vice President acquired 3,698 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 4,461 shares (grant or award)
- 4 Open-market buy Director bought 20,000 shares at $1.39 ($27,800)
- 4 Open-market buy Senior Vice President bought 8,000 shares at $1.39 ($11,120)
- 4 Open-market buy Chief Executive Officer bought 30,000 shares at $1.39 ($41,700)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Scientific Officer acquired 1,256 shares (grant or award)
- 4 Grant or award Senior Vice President acquired 2,246 shares (grant or award)
Page 3 of 41 · 806 filings